High-performance invasive brain-computer interface nears clinical validation stage
According to Li, by working with Peking University First Hospital, Xuanwu Hospital Capital Medical University and Beijing Tiantan Hospital of the Capital Medical University, Neucyber Neurotech has finished five Beinao-1 implantation operations since the beginning of 2025, delivering motor and speech rehabilitation and functional substitution for individuals with spinal cord injuries, stroke, or amyotrophic lateral sclerosis.
Beinao-1 is the world's first high-throughput wireless fully implanted BCI system and is an electroencephalogram-based BCI system.
"Next, we will complete the official registered clinical trial for the Beinao-1 intelligent BCI system, continuing to advance technological optimization and application expansion, bringing hope to more patients," Li added.
- IP protection for new fields to improve
- Draft rules define premade dishes in consumer interest
- Self-powering pacemaker could last a lifetime
- China intensifies crackdown on misuse of personal data
- China issues new rules classifying online content harmful to minors
- Chinese vice-premier urges efforts to consolidate poverty alleviation achievements
